- Release Date: 31/03/23 17:47
- Summary: Positive Final Data in 2nd Line Metastatic NSCLC Patients
- Price Sensitive: Yes
- Download Document 283.42KB
Ann: Positive Final Data in 2nd Line Metastatic NSCLC Patients
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
44.0¢ |
Change
0.020(4.76%) |
Mkt cap ! $523.0M | |||
| Open | High | Low | Value | Volume |
| 42.0¢ | 44.5¢ | 42.0¢ | $634.8K | 1.476M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 34960 | 44.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 44.5¢ | 30034 | 9 |
View Market Depth
| Last trade - 14.20pm 29/04/2024 (20 minute delay) ? |
|
|||||
|
Last
44.0¢ |
Change
0.020 ( 4.34 %) |
||||
| Open | High | Low | Volume | ||
| 42.5¢ | 44.0¢ | 42.0¢ | 487806 | ||
| Last updated 14.36pm 29/04/2024 ? | |||||
| IMM (ASX) Chart |